Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantation

Cancer Treat Res. 2009:144:539-73. doi: 10.1007/978-0-387-78580-6_21.

Authors

Juan C Gea-Banacloche¹, James C Wade

Affiliation

¹ Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. banacloj@mail.nih.gov

PMID: 19779875
DOI: 10.1007/978-0-387-78580-6_21

No abstract available

Publication types

Review

MeSH terms

Aspergillosis / etiology
Bacterial Infections / complications
Bacterial Infections / etiology
Communicable Diseases / complications
Drug Resistance, Bacterial
Fever
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cell Transplantation / methods*
Humans
Immune System
Medical Oncology / methods
Mycoses / etiology
Neutropenia / microbiology
Pneumococcal Infections / complications
Pneumococcal Infections / immunology
Vancomycin / pharmacology

Substances

Vancomycin